[go: up one dir, main page]

AR082633A1 - Analogos de tetraciclina - Google Patents

Analogos de tetraciclina

Info

Publication number
AR082633A1
AR082633A1 ARP110102925A ARP110102925A AR082633A1 AR 082633 A1 AR082633 A1 AR 082633A1 AR P110102925 A ARP110102925 A AR P110102925A AR P110102925 A ARP110102925 A AR P110102925A AR 082633 A1 AR082633 A1 AR 082633A1
Authority
AR
Argentina
Prior art keywords
alkyl
carbocyclyl
alkylene
heterocyclyl
fluoroalkyl
Prior art date
Application number
ARP110102925A
Other languages
English (en)
Original Assignee
Tetraphase Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tetraphase Pharmaceuticals Inc filed Critical Tetraphase Pharmaceuticals Inc
Publication of AR082633A1 publication Critical patent/AR082633A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/60—1,4-Diazines; Hydrogenated 1,4-diazines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/84—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms six-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/38—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/04—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

También se describe una composición farmacéutica que comprende el compuesto de fórmula estructural (1) y su uso terapéutico, en infecciones bacterianas.Reivindicación 1: Un compuesto de fórmula (1), o una sal farmacéuticamente aceptable del mismo, donde X se selecciona entre hidrógeno, bromo, flúor, cloro, alquilo C1-6, -O-alquilo C1-6, carbociclilo C3-10, -O-carbociclilo C3-10, heterociclilo de 4 - 13 miembros, -O-heterociclilo de 4 - 13 miembros, S(O)m-R2, -CN, N(R2)(R3), -S(O)mN(R2)(R3), -C(O)-O-R2, -C(O)-N(R2)(R3) y -NH-C(O)-alquileno C1-6-N(R2)(R3), donde cada alquilo o alquileno en el grupo representado por X está opcionalmente sustituido con uno o más flúor; y cada carbociclilo o heterociclilo en el grupo representado por X está opcionalmente sustituido con uno o más sustituyentes seleccionados independientemente entre flúor, cloro, =O, -OH, fluoroalquilo C1-4, alquilo C1-4, -O-alquilo C1-4, -O-fluoroalquilo C1-4, -NH2, -NH(alquilo C1-4) o -N(alquilo C1-4)2, carbociclilo C3-10 o un heterociclilo de 4 - 13 miembros; el anillo E se selecciona entre carbociclilo C3-10 y un heterociclilo de (4 - 13 miembros); W se selecciona entre C(R6), C(R6)2, N y N(R7); Q se selecciona entre C(R6), C(R6)2, N, N(R7), O y S; Y se selecciona entre hidrógeno, flúor, bromo, -CN, -[C(R1a)(R1b)]n-N(R2)(R3), -N(R4)(R5), NO2, -NH-C(O)-alquileno C1-4-N(R4)(R5), alquilo C1-6, -NH-C(O)-alquilo C1-6, -NH-S(O)m-alquilo C1-6, -NH-S(O)m-carbociclilo C3-10, -NH-S(O)m-heterociclilo de 4 - 13 miembros; cada R1a y R1b se selecciona independientemente entre hidrógeno, alquilo C1-4 y carbociclilo C3-10; R2 se selecciona entre hidrógeno, alquilo C1-12, -alquileno C0-6-carbociclilo C3-10 y -alquileno C0-6-heterociclilo de 4 - 13 miembros; R3 se selecciona entre hidrógeno, alquilo C1-8, -alquileno C0-6-carbociclilo C3-10, -alquileno C0-6-heterociclilo de 4 - 13 miembros, -C(O)-alquilo C1-6, -alquileno C0-6-C(O)N(R4)(R5), -C(O)-alquileno C1-6-N(R4)(R5), -alquileno C2-6-N(R4)(R5), -S(O)m-alquilo C1-6, -S(O)m-carbociclilo C3-10 y -S(O)m-heterociclilo de 4 - 13 miembros, donde: cada alquilo, carbociclilo, alquileno o heterociclilo en el grupo representado por R2 o R3 está opcional e independientemente sustituido con uno o más sustituyentes seleccionados independientemente entre flúor, cloro, -OH, -O-alquilo C1-4, alquilo C1-4, alquilo C1-4 sustituido con flúor, -N(R4)(R5), carbociclilo C3-10 o un heterociclilo de 4 - 13 miembros; o R2 y R3 tomados junto con el átomo de nitrógeno al que están unidos forman un anillo heterocíclico monocíclico de 4 - 7 miembros, o un anillo heterocíclico, bicíclico, espirocíclico o puenteado, donde el anillo heterocíclico monocíclico de 4 - 7 miembros, o el anillo heterocíclico, bicíclico, espirocíclico o puenteado, de 6 - 13 miembros, comprende opcionalmente de 1 a 4 heteroátomos adicionales seleccionados independientemente entre N, S y O; el anillo heterocíclico monocíclico de 4 - 7 miembros, o el anillo heterocíclico, bicíclico, espirocíclico o puenteado, de 6 - 13 miembros, está opcionalmente sustituido con uno o más sustituyentes seleccionados independientemente entre carbociclilo C3-10, heterociclilo de 4 - 13 miembros, flúor, cloro, -OH, -fluoroalquilo C1-4, -alquilo C1-4, -O-carbociclilo C3-10, -O-heterociclilo de 4 - 13 miembros, -alquileno C0-4-O-alquilo C1-4, -alquileno C0-4-O-fluoroalquilo C1-4, =O, -C(O)-alquilo C1-4, -C(O)N(R4)(R5), -N(R4)-C(O)-alquilo C1-4 y -alquileno C0-4-N(R4)(R5), y cada sustituyente carbociclilo o heterociclilo está opcionalmente sustituido con flúor, cloro, -OH, =O, fluoroalquilo C1-4, alquilo C1-4, -O-alquilo C1-4, -O-fluoroalquilo C1-4, -NH2, -NH(alquilo C1-4) o -N(alquilo C1-4)2; cada uno de R4 y R5 se selecciona independientemente entre hidrógeno y alquilo C1-4; o R4 y R5 tomados junto con el átomo de nitrógeno al que están unidos forman un anillo heterocíclico de 4 - 7 miembros que comprende opcionalmente un heteroátomo adicional seleccionado entre N, S y O, donde el anillo heterocíclico de 4 - 7 miembros está opcionalmente sustituido con flúor, cloro, -OH, =O, alquilo C1-4 sustituido con flúor, -alquilo C1-4 o -alquileno C1-4-O-alquilo C1-4, y está opcionalmente condensado con fenilo; cada R6 se selecciona independientemente entre hidrógeno, carbociclilo C3-10, heterociclilo de 4 - 13 miembros, flúor, cloro, -OH, fluoroalquilo C1-4, alquilo C1-4, -O-carbociclilo C3-10, -O-heterociclilo de 4 - 13 miembros, -alquil C0-4-O-alquilo C1-4, -alquil C0-4-O-fluoroalquilo C1-4, -C(O)-alquilo C1-4, -C(O)N(R4)(R5), -N(R4)-C(O)-alquilo C1-4 y -alquileno C0-4-N(R4)(R5); o C(R6)2 es C=O; cada R7 se selecciona independientemente entre hidrógeno, -alquileno C0-4-carbociclilo C3-10, -alquileno C0-4-heterociclilo de 4 - 13 miembros, -fluoroalquilo C1-6, -alquilo C1-6, hidroxialquilo C1-6, -O-carbociclilo C3-10, -O-heterociclilo de 4 - 13 miembros, -alquileno C0-4-O-alquilo C1-4, -alquileno C0-4-O-fluoroalquilo C1-4, -C(O)-alquilo C1-4, -alquileno C1-4-C(O)-alquilo C1-4, -alquileno C1-4-C(O)-OH, -C(O)N(R4)(R5), -N(R4)-C(O)-alquilo C1-4, -C(O)-(alquileno C1-4)-NR4R5 y -alquileno C0-4-N(R4)(R5); y cada porción carbociclilo o heterociclilo de R6 y R7 está opcionalmente sustituida con flúor, cloro, -OH, =O, fluoroalquilo C1-4, alquilo C1-4, -O-alquilo C1-4, -O-fluoroalquilo C1-4, -NH2, -NH(alquilo C1-4) o -N(alquilo C1-4)2; cada R8 se selecciona independientemente entre hidrógeno, carbociclilo C3-10, heterociclilo de 4 - 13 miembros, flúor, cloro, -OH, fluoroalquilo C1-4, alquilo C1-4, -O-carbociclilo C3-10, -O-heterociclilo de 4 - 13 miembros, -alquil C0-4-O-alquilo C1-4, -alquil C0-4-O-fluoroalquilo C1-4, =O, -C(O)-alquilo C1-4, -C(O)N(R4)(R5), -N(R4)-C(O)-alquilo C1-4, -alquileno C0-4-N(R4)(R5) y - S(O)2alquilo C1-4; R9 está ausente o se selecciona independientemente entre hidrógeno, carbociclilo C3-10, heterociclilo de 4 - 13 miembros, flúor, cloro, -OH, fluoroalquilo C1-4, alquilo C1-4, -O-carbociclilo C3-10, -O-heterociclilo de 4 - 13 miembros, -alquil C0-4-O-alquilo C1-4, -alquil C0-4-O-fluoroalquilo C1-4, =O, -C(O)-alquilo C1-4, -C(O)N(R4)(R5), -N(R4)-C(O)-alquilo C1-4 y -alquileno C0-4-N(R4)(R5); cada m es independientemente 0, 1 ó 2; n es 1 ó 2; p es 0 o un número entero entre 1 y 4; y cada - - - - - representa un enlace sencillo o un doble enlace, donde al menos uno de - - - - - representa un enlace sencillo, con la condición de que cuando el Anillo E es un anillo aromático opcionalmente sustituido o heteroaromático opcionalmente sustituido, X no sea hidrógeno.
ARP110102925A 2010-08-12 2011-08-11 Analogos de tetraciclina AR082633A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37319010P 2010-08-12 2010-08-12
US201061424552P 2010-12-17 2010-12-17
US201161483025P 2011-05-05 2011-05-05

Publications (1)

Publication Number Publication Date
AR082633A1 true AR082633A1 (es) 2012-12-19

Family

ID=45567944

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110102925A AR082633A1 (es) 2010-08-12 2011-08-11 Analogos de tetraciclina

Country Status (3)

Country Link
AR (1) AR082633A1 (es)
TW (1) TW201245116A (es)
WO (1) WO2012021712A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5496202B2 (ja) 2008-08-08 2014-05-21 テトラフェース ファーマシューティカルズ，インコーポレイテッド Ｃ７−フルオロ置換テトラサイクリン化合物
ES2553968T3 (es) 2008-09-18 2015-12-15 Northwestern University Moduladores del receptor NMDA y sus usos
PL2427425T3 (pl) 2009-05-08 2017-08-31 Tetraphase Pharmaceuticals, Inc. Związki tetracyklinowe
EP2470500B1 (en) 2009-08-28 2017-10-04 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
KR102375238B1 (ko) * 2012-08-31 2022-03-15 테트라페이즈 파마슈티컬스, 인코포레이티드 테트라사이클린 화합물
EP3514158B1 (en) 2013-01-29 2022-10-12 Aptinyx Inc. Spiro-lactam nmda receptor modulators and uses thereof
JP6793715B2 (ja) 2015-03-23 2020-12-02 バイオファーミクス・インコーポレイテッドＢｉｏＰｈａｒｍＸ， Ｉｎｃ． テトラサイクリンの皮膚用医薬組成物
US11299495B2 (en) 2016-08-01 2022-04-12 Aptinyx Inc. Spiro-lactam NMDA receptor modulators and uses thereof
AU2017306158B2 (en) 2016-08-01 2021-10-14 Aptinyx Inc. Spiro-lactam and bis-spiro-lactam NMDA receptor modulators and uses thereof
MX2019001308A (es) 2016-08-01 2019-05-30 Aptinyx Inc Moduladores nmda espiro-lactam y metodos de uso de los mismos.
EP3490993B1 (en) 2016-08-01 2023-12-06 Tenacia Biotechnology (Hong Kong) Co., Limited Spiro-lactam nmda receptor modulators and uses thereof
CA3031534C (en) 2016-08-01 2023-10-17 Aptinyx Inc. Spiro-lactam nmda receptor modulators and uses thereof
EP3506908A1 (en) 2016-08-30 2019-07-10 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds and methods of treatment
PH12019500822B1 (en) 2016-10-19 2024-02-21 Tetraphase Pharmaceuticals Inc Crystalline forms of eravacycline
BR112020015710A2 (pt) 2018-01-31 2020-12-08 Aptinyx Inc. Moduladores de espiro-lactamas de receptores nmda e usos dos mesmos
US12012413B2 (en) 2019-11-11 2024-06-18 Tenacia Biotechnology (Hong Kong) Co., Limited Methods of treating painful diabetic peripheral neuropathy
CN113444070A (zh) * 2021-07-28 2021-09-28 深圳市真味生物科技有限公司 一种由手性叔丁基亚磺酰胺合成手性尼古丁的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1303479B1 (en) * 2000-07-07 2011-04-06 Trustees Of Tufts College 7-, 8- and 9-substituted tetracycline compounds
US20060194773A1 (en) * 2001-07-13 2006-08-31 Paratek Pharmaceuticals, Inc. Tetracyline compounds having target therapeutic activities
EP2316450A1 (en) * 2002-03-08 2011-05-04 Paratek Pharmaceuticals, Inc. Amino-methyl substituted tetracycline compounds
EP1910273A2 (en) * 2005-07-21 2008-04-16 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
JP5496202B2 (ja) * 2008-08-08 2014-05-21 テトラフェース ファーマシューティカルズ，インコーポレイテッド Ｃ７−フルオロ置換テトラサイクリン化合物

Also Published As

Publication number Publication date
TW201245116A (en) 2012-11-16
WO2012021712A1 (en) 2012-02-16

Similar Documents

Publication Publication Date Title
AR082633A1 (es) Analogos de tetraciclina
PE20110835A1 (es) Piridiloxi-indoles inhibidores del vegf-r2 y uso de los mismos para el tratamiento de enfermedades
AR053195A1 (es) Compuestos inhibidores de dipeptidil peptidasa-iv metodos para preparar los mismos y composiciones farmaceuticas que los contienen como un agente activo
AR077505A1 (es) Compuestos de piridina y sus usos
AR054035A1 (es) Derivados benzodioxano y benzodioxolano y uso de los mismos
AR087184A1 (es) Derivados de azaindol utiles para tratar infecciones por hiv y composiciones farmaceuticas que los contienen
PE20140011A1 (es) Compuestos y composiciones novedosos para la inhibicion de nampt
ECSP11011561A (es) Derivados aminobutíricos sustituidos como inhibidores de neprilisina
PE20142456A1 (es) COMPUESTOS DE OXAZOLIDIN-2-ONA Y USOS DE LOS MISMOS COMO INHIBIDORES DE LA PI3Ks
AR067757A1 (es) Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales.
AR082391A1 (es) Inhibidores biciclicos de acetil-coa y usos de los mismos
UY32462A (es) Derivados de bifenilo novedosos para el tratamiento de infección por virus de hepatitis c 644
AR063240A1 (es) Derivados de n-aril pirazol,composiciones farmaceuticas que los contienen y usos para el tratamiento de la diabetes tipo2,y enfermedades relacionadas.
EA201490634A1 (ru) Производные полимиксина
EA200970510A1 (ru) Гетеромоноциклическое соединение и его применение
PE20141582A1 (es) Pirimidinas anilladas sustituidas y uso de las mismas
AR072952A1 (es) Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso
GB201201744D0 (en) Novel compounds
AR064657A1 (es) 8- alquinilxantinas y derivados
AR063804A1 (es) Compuestos de azoniabiciclo[2.2.2]octano
MY184433A (en) 2,6-substituted purine derivatives and their use in the treatment of proliferative disorders
PE20142081A1 (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodo de uso de los mismos
AR086100A1 (es) Compuestos de cromenona y composiciones farmaceuticas que los contienen
EA201590022A1 (ru) Новые производные 1,3-дигидро-2h-бензимидазол-2-она, замещенные гетероциклами, в качестве противовирусных средств против респираторного синцитиального вируса
AR082498A1 (es) Derivados ciclicos de carboxamida y urea sustituidos como ligandos del receptor de vainiloide

Legal Events

Date Code Title Description
FB Suspension of granting procedure